Joint DIA/ICOS Conference on Cardiac Toxicity 2014 Prague

  • Conference Call
  • The Joint DIA/​ICOS Con­fer­ence on Car­diac Tox­i­c­ity will held in Prague, Czech Repub­lic on Octo­ber 9 – 10, 2014 at the Dorit Praha Don Gio­vanni Hotel.

    Overview

    There is a tremen­dous amount of mech­a­nis­tic over­lap between tar­geted can­cer ther­apy and car­dio­vas­cu­lar tis­sues. Impor­tant drugs that may be active on can­cer­ous tis­sues are increas­ingly likely to have sig­nif­i­cant col­lat­eral effects on car­diac tis­sues. Under­stand­ing the under­ly­ing mech­a­nisms and how to detect these prob­lems early and man­age them effec­tively can allow a crit­i­cal drug for can­cer effi­cacy to con­tinue to develop as a clin­i­cal therapy.

    Addi­tion­ally, tai­lor­ing the phar­ma­col­ogy of a poten­tial can­cer ther­a­peu­tic based on known mech­a­nis­tic insights is an essen­tial area of pre­clin­i­cal devel­op­ment. Fur­ther­more, enhanc­ing inter­ac­tions between car­di­ol­ogy and oncol­ogy at all lev­els of clin­i­cal tri­als allows for opti­mal patient outcomes.

    Learn­ing Objectives

    • Describe the best meth­ods of car­diotox­i­c­ity detec­tion dur­ing early phase clin­i­cal trials
    • Under­stand the best man­age­ment approaches to pro­tect­ing car­diac tis­sues dur­ing aggres­sive can­cer therapy
    • Detail known and the­o­rised mech­a­nis­tic actions of devel­op­ing can­cer ther­apy to allow cardioprotection
    • Estab­lish and ensure effec­tive com­mu­ni­ca­tion between drug devel­op­ers and prescribers
    • Pro­mote opti­mal patient care between car­di­ol­ogy and oncology

    Who Should Attend

    • Car­di­ol­ogy, oncol­ogy and pri­mary care physi­cians, nurse prac­tion­ers, and other allied providers
    • Drug devel­op­ment and clin­i­cal research man­agers and associates
    • Phar­ma­covig­i­lance, drug safety and drug sur­veil­lance personnel
    • Phar­ma­ceu­ti­cal physi­cians and med­ical directors
    • Safety phar­ma­col­ogy and non-​clinical scientists
    • Clin­i­cal phar­ma­col­ogy scientists
    • Reg­u­la­tory affairs officers
    • Bio­sta­tis­ti­cians
    • Data man­agers
    • Out­sourc­ing and mar­ket­ing managers

    Pro­gram Committee

    • Boaz Mendzelevski, MD – Vice Pres­i­dent of Car­di­ol­ogy, Bio­Clin­ica Inc., United Kingdom
    • Daniel J. Leni­han, Dr. Med, FACC – Direc­tor, Car­dio­vas­cu­lar Clin­i­cal Research; Prof, Div. Car­dio­vas­cu­lar Med­i­cine, Van­der­bilt Uni­ver­sity, United States
    • Krishna Prasad, MD, FRCP – Man­ager, CV-​Diabetes Unit/​Consultant Car­di­ol­o­gist, Med­i­cines and Health­care prod­ucts Reg­u­la­tory Agency (MHRA), United Kingdom
    starting: ending: 10.10.2014 Location: , Category:

    Timeline

    Conference START 10.10.2014 END

    All deadlines have expired!

    This conference has no more open deadlines. There may be successive conferences coming up you may by interested in.

    Please check our conference list and search...

    Conference Facts

    Location , Address Vinohradská 157a Category More Info Conference Website

    Further interesting Conferences

    Currently we have no similar events listed. Please check our website regulary, subscribe to our RSS-Feed or follow us on twitter for new listings.